Home / Inspections / 1040785

FDA Inspection 1040785 — Nesher Pharmaceuticals (USA) LLC

Nesher Pharmaceuticals (USA) LLC — FEI 1922352

The FDA completed an inspection of Nesher Pharmaceuticals (USA) LLC on January 11, 2018 in Bridgeton, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 11, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bridgeton, MO (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1151199 (VAI Thu Aug 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1092585 (VAI Fri May 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1002473 (VAI Fri Feb 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 926755 (VAI Thu May 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 854899 (NAI Fri Nov 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources